Department of Health and Human Services, Food and Drug Administration, Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act, January 2018.
The SURMOUNT-MMO trial should provide definitive answers about Tirzepatides cardiovascular benefits within the next few years
Managing Melasma During the Winter Months By Kari Brogan February 2, 2026 Melasma is a chronic pigmentation condition that causes symmetrical patches of brown or gray-brown discoloration, most commonly on the cheeks, forehead, upper lip, and jawline
This guide reflects Novi's current published program terms, the FDA's April 30, 2026 proposed rule on compounded GLP-1 medications, and the June 29, 2026 public comment deadline
Key Highlights: The exquisite and nourishing Makari Blue Crystal Skin Reviving Body Lotion is designed specifically to hydrate and revitalise skin
